Login / Signup

Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti-TNF and anti-interleukin-17 failures.

Raffaele Dante Caposiena CaroChiara PensaSara LambiaseEleonora CandiLuca Bianchi
Published in: Dermatologic therapy (2021)
Keyphrases
  • hidradenitis suppurativa
  • randomized controlled trial
  • systematic review